Oxidized LDLs (ox.LDLs) uptake by macrophages inside the arterial wall is a crucial step in atherosclerotic disease, and some studies suggest that high ox.LDLs plasma levels might be associated with cardiovascular disease (CVD). However, whether high ox.LDLs continue to be a CVD risk factors in older persons is unknown. We investigated the clinical correlates of plasma ox.LDLs, and their role in predicting longterm CVD/cardiac mortality in 1025 older community dwelling individuals (mean age: 75.5 7.4 years; females: 55%) from the InCHIANTI study. KaplaneMeier curves were fitted to explore the relationship between tertiles of ox.LDLs (ox.LDL/LDL-C ratio) and time to CVD/cardiac death. Hazard Ratios (HR) were estimated by Cox regression analysis. At multivariate analysis, ox.LDLs were independently associated with LDL-C, triglycerides, and HDL-C (adjusted r2: 0.42; P ¼ 0.001). The ox.LDL/LDL-C ratio (the extent of LDLs oxidation) was independently correlated with HDL-C, triglycerides, and beta-carotene (adjusted r2: 0.15, P ¼ 0.001). Among 1025 individuals, 392 died after 9 years, 166 from CVD. The HR for CVD/cardiac mortality was not significantly different across tertiles of ox.LDLs or ox.LDL/LDL-C ratio, both in the whole sample and in individuals with prevalent CVD. We conclude that in an elderly population LDL-C, triglycerides, and HDL-C are the most important determinants of ox.LDLs levels, indirectly suggesting an association between small dense LDLs and LDLs oxidation. No association emerged between higher ox.LDLs levels and 9 years CVD/cardiac mortality, suggesting that in advanced age the prognostic information added by ox.LDLs on CVD/cardiac mortality might be negligible.

Determinants and clinical significance of plasma oxidized LDLs in older individuals. A 9 years follow-up study / G., Zuliani; Morieri, M. L.; S., Volpato; Vigna, G. B.; C., Bosi; Maggio, Marcello Giuseppe; A., Cherubini; S., Bandinelli; Guralnik, J. M.; L., Ferrucci. - In: ATHEROSCLEROSIS. - ISSN 0021-9150. - 226:1(2013), pp. 201-207. [10.1016/j.atherosclerosis.2012.10.028]

Determinants and clinical significance of plasma oxidized LDLs in older individuals. A 9 years follow-up study

MAGGIO, Marcello Giuseppe;
2013-01-01

Abstract

Oxidized LDLs (ox.LDLs) uptake by macrophages inside the arterial wall is a crucial step in atherosclerotic disease, and some studies suggest that high ox.LDLs plasma levels might be associated with cardiovascular disease (CVD). However, whether high ox.LDLs continue to be a CVD risk factors in older persons is unknown. We investigated the clinical correlates of plasma ox.LDLs, and their role in predicting longterm CVD/cardiac mortality in 1025 older community dwelling individuals (mean age: 75.5 7.4 years; females: 55%) from the InCHIANTI study. KaplaneMeier curves were fitted to explore the relationship between tertiles of ox.LDLs (ox.LDL/LDL-C ratio) and time to CVD/cardiac death. Hazard Ratios (HR) were estimated by Cox regression analysis. At multivariate analysis, ox.LDLs were independently associated with LDL-C, triglycerides, and HDL-C (adjusted r2: 0.42; P ¼ 0.001). The ox.LDL/LDL-C ratio (the extent of LDLs oxidation) was independently correlated with HDL-C, triglycerides, and beta-carotene (adjusted r2: 0.15, P ¼ 0.001). Among 1025 individuals, 392 died after 9 years, 166 from CVD. The HR for CVD/cardiac mortality was not significantly different across tertiles of ox.LDLs or ox.LDL/LDL-C ratio, both in the whole sample and in individuals with prevalent CVD. We conclude that in an elderly population LDL-C, triglycerides, and HDL-C are the most important determinants of ox.LDLs levels, indirectly suggesting an association between small dense LDLs and LDLs oxidation. No association emerged between higher ox.LDLs levels and 9 years CVD/cardiac mortality, suggesting that in advanced age the prognostic information added by ox.LDLs on CVD/cardiac mortality might be negligible.
2013
Determinants and clinical significance of plasma oxidized LDLs in older individuals. A 9 years follow-up study / G., Zuliani; Morieri, M. L.; S., Volpato; Vigna, G. B.; C., Bosi; Maggio, Marcello Giuseppe; A., Cherubini; S., Bandinelli; Guralnik, J. M.; L., Ferrucci. - In: ATHEROSCLEROSIS. - ISSN 0021-9150. - 226:1(2013), pp. 201-207. [10.1016/j.atherosclerosis.2012.10.028]
File in questo prodotto:
File Dimensione Formato  
determinants and clinical significance of LDL.pdf

non disponibili

Tipologia: Documento in Post-print
Licenza: Creative commons
Dimensione 318.42 kB
Formato Adobe PDF
318.42 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2531664
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 24
  • ???jsp.display-item.citation.isi??? 23
social impact